Category: St. Jude Medical
MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.
MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
Nanosphere prices its offering of 15 million shares at $1.75 apiece, saying it aims raise more than $26 million for its molecular diagnostics technology.
Nanosphere (NSDQ:NSPH) said it priced a public offering of 15 million shares at $1.75 apiece, aiming to drum up a minimum of $26.3 million for its molecular diagnostics technology.
The family of Dr. Michel Mirowski, credited with inventing the implantable cardioverter defibrillator, takes Boston Scientific to court over alleged secret deal with St. Jude Medical.
A federal appeals court partially overturns a lower court's ruling in favor of St. Jude Medical in a lawsuit against Access Closure over vascular closure patents.
The FDA's Circulatory System Devices Panel will in October reconsider CardioMEMs' once-rejected application for its Champion heart failure monitoring system, a potential boon for stakeholder St. Jude Medical.
Once-rejected CardioMEMs will get another shot at FDA approval for its Champion implantable heart failure monitoring systems when the agency's Circulatory System Devices Panel convenes next month, according to a notice in the Federal Register.
California-based Spinal Modulation enrolls the 1st patient in its ACCURATE clinical trial to evaluate its Axium neurostimulation system for management of chronic lower limb pain, a technology that St. Jude Medical has under an exclusive acquisition option.
St. Jude Medical wins CE Mark approval in the European Union for its next-generation EnligHTN renal denervation system, which can purportedly ablation time by as much as 80%.